Clinical Neurotechnology

A Gentle, Targeted Approach to the Brain

Understanding the physics, neuroscience, and clinical indications of Transcranial Magnetic Stimulation (TMS).

Mechanism of TMS cortical excitation and neuroplasticity
How TMS Works

Electromagnetic Neurostimulation & Neuroplasticity

Transcranial Magnetic Stimulation operates on the fundamental medical physics principle of electromagnetic induction discovered by Michael Faraday. A specialized electromagnetic coil placed against the scalp generates alternating magnetic fields that pass effortlessly through hair, skin, and skull bone without resistance or sensation.

When these magnetic pulses reach the cerebral cortex, they induce brief, localized electrical micro-currents. These micro-currents depolarize cortical neurons, stimulating them to fire and release vital neurotransmitters including serotonin, dopamine, and norepinephrine.

Over a multi-week treatment course, repeated targeted stimulation produces lasting Long-Term Potentiation (LTP) — the biological basis of neuroplasticity. The brain literally rewires underactive mood networks, re-establishing resilient cognitive control.

Interactive Protocol Matrix

Clinical Treatment Parameters & Indications

Select an indication below to review its neuro-anatomical target, stimulation frequency, session duration, and clinical evidence.

FDA Cleared since 2008

Major Depressive Disorder (MDD)

Depression is biologically characterized by hypometabolism in the Left Dorsolateral Prefrontal Cortex (L-DLPFC). When this area goes dormant, patients experience persistent despair, cognitive fog, emotional numbness, and an inability to experience joy (anhedonia).

Our high-frequency (10Hz) excitatory protocol stimulates the L-DLPFC, restoring metabolic blood flow and normal neurotransmitter equilibrium. Over 70% of patients who failed to improve on traditional medications achieve meaningful clinical response, with approximately 50% reaching complete remission.

Inquire About Depression Protocol

Depression Treatment Parameters

  • Target: Left Dorsolateral Prefrontal Cortex (DLPFC)
  • Protocol: High-frequency (10Hz) or iTBS (theta burst)
  • Session Duration: 19 to 30 minutes
  • Course Duration: 30 to 36 sessions (5 days/week)
  • Suitability: Treatment-resistant depression, medication intolerance
Clinical Evidence

Generalized Anxiety & Panic Disorders

Severe anxiety is driven by hyperarousal of the limbic system, particularly the amygdala, accompanied by an overactive right prefrontal cortex. Patients experience racing thoughts, physical tension, insomnia, and pervasive dread.

We employ a low-frequency (1Hz) inhibitory protocol applied to the Right DLPFC. This gently dampens hyperactive threat-detection circuits, restoring calm and reducing somatic panic symptoms without the sedative cloud of benzodiazepines.

Inquire About Anxiety Protocol

Anxiety Treatment Parameters

  • Target: Right Dorsolateral Prefrontal Cortex (R-DLPFC)
  • Protocol: Low-frequency (1Hz) inhibitory stimulation
  • Session Duration: 20 to 25 minutes
  • Course Duration: 25 to 30 sessions
  • Suitability: GAD, panic disorder, comorbid anxiety with depression
FDA Cleared Protocol

Obsessive-Compulsive Disorder (OCD)

OCD involves hyper-synchronized firing in the Cortico-Striato-Thalamo-Cortical (CSTC) loop, trapping patients in distressing intrusive obsessions and repetitive neutralizing compulsions.

Using specialized targeted stimulation coils, TMS modulates anterior cingulate and medial prefrontal regions. Delivered in conjunction with personalized symptom provocation protocols, TMS significantly reduces obsessive symptom severity on the Y-BOCS scale.

Inquire About OCD Protocol

OCD Treatment Parameters

  • Target: Medial Prefrontal Cortex / Anterior Cingulate
  • Protocol: 20Hz high-frequency deep modulation
  • Session Duration: 20 minutes
  • Course Duration: 29 to 30 sessions
  • Suitability: Refractory OCD, SSRI-resistant symptoms
Emerging Neuro-Therapeutics

Chronic Neuropathic Pain & Tinnitus

Centralized pain disorders and intractable tinnitus represent neural network maladaptations — "phantom pain" and "phantom sound" generated by hyperactive sensory cortices.

By targeting the Primary Motor Cortex (M1) or Temporoparietal junction, TMS activates descending inhibitory pain pathways, offering non-opioid, non-surgical relief for chronic neuropathic conditions.

Inquire About Pain Protocol

Pain & Tinnitus Parameters

  • Target: Primary Motor Cortex (M1) or Auditory Cortex
  • Protocol: High-frequency pain-gating modulation
  • Session Duration: 20 to 30 minutes
  • Course Duration: 20 to 30 sessions
  • Suitability: Neuropathic pain, fibromyalgia, refractory tinnitus
Comparative Clinical Science

TMS vs. Medications vs. Electroconvulsive Therapy

Review the clinical evidence comparing Transcranial Magnetic Stimulation against traditional pharmaceutical and electrical interventions.

← Swipe left/right to compare →
Clinical Feature TMS Therapy (UPPS Wellness) Antidepressant Medications Electroconvulsive Therapy (ECT)
Invasiveness Non-Invasive (Outpatient) Non-Invasive (Oral) Invasive (Hospital Inpatient)
Anaesthetic / Sedation None Required (100% Awake) None General Anaesthetic & Muscle Relaxant
Systemic Side Effects Zero (No weight gain, nausea, sexual dysfunction) Common & Often Severe Frequent cardiovascular & physical strain
Cognitive / Memory Impact Pro-Cognitive (Improves memory & clarity) Can cause emotional blunting & brain fog Significant risk of acute & retrograde memory loss
Post-Treatment Activity Immediate resumption (Drive yourself home) Daily continuous dosage Requires escort home & 24h+ recovery downtime
Mechanism Targeted electromagnetic cortical stimulation Broad chemical bloodstream distribution Generalized induced cerebral seizure
Safety & Tolerability

Who Can Safely Receive TMS?

TMS has an exceptionally high safety profile documented across hundreds of thousands of treatment sessions worldwide. Because it is non-systemic, there are no medication interactions or organ burdens.

Absolute Contraindications

The only absolute contraindication is the presence of non-removable metallic or electronic implants situated within 30cm of the treatment coil, including metallic aneurysm clips, cochlear implants, and implanted brain stimulators.

What is Completely Safe

Dental fillings, dental braces, titanium implants, cardiac stents, and joint replacements below the neck are completely safe and do not interfere with TMS.

Clinical Side Effect Profile

Mild Scalp Sensitivity: Some patients note a light tingling or mild tension headache during the initial 3-4 sessions, which typically resolves spontaneously or responds to standard over-the-counter paracetamol.

No Cognitive Deficits: Decades of testing confirm TMS does not impair memory, concentration, or intelligence.

Extremely Low Seizure Risk: Less than 0.1% per course — comparable to or lower than the seizure risk of many standard antidepressant medications.

Chat with Clinic
Call Book Visit